Su C - Search Results

1

OCT4 positively regulates Survivin expression to promote cancer cell proliferation and leads to poor prognosis in esophageal squamous cell carcinoma.

Li C, Yan Y, Ji W, Bao L, Qian H, Chen L, Wu M, Chen H, Li Z, Su C. Li C, et al. Among authors: su c. PLoS One. 2012;7(11):e49693. doi: 10.1371/journal.pone.0049693. Epub 2012 Nov 21. PLoS One. 2012. PMID: 23185410 Free PMC article.

2

[Treatment of hepatocellular carcinoma by transfecting interleukin-12 and interleukin-2 fusion gene intrasplenically, an experimental study].

Yang JH, Fan RF, Qian QJ, You TG, Xue HB, Su CQ, Cao HF, Wu MC. Yang JH, et al. Zhonghua Yi Xue Za Zhi. 2003 May 10;83(9):740-3. Zhonghua Yi Xue Za Zhi. 2003. PMID: 12899748 Chinese.

3

Effective gene-viral therapy for telomerase-positive cancers by selective replicative-competent adenovirus combining with endostatin gene.

Zhang Q, Nie M, Sham J, Su C, Xue H, Chua D, Wang W, Cui Z, Liu Y, Liu C, Jiang M, Fang G, Liu X, Wu M, Qian Q. Zhang Q, et al. Among authors: su c. Cancer Res. 2004 Aug 1;64(15):5390-7. doi: 10.1158/0008-5472.CAN-04-1229. Cancer Res. 2004. PMID: 15289347

4

[Treatment of hepatocellular carcinoma with a novel gene-viral therapeutic system CNHK300-murine endostatin].

Li GC, Nie MM, Yang JM, Su CQ, Sun LC, Qian YZ, Sham J, Fang GE, Wu MC, Qian QJ. Li GC, et al. Zhonghua Yi Xue Za Zhi. 2004 Jun 2;84(11):943-8. Zhonghua Yi Xue Za Zhi. 2004. PMID: 15329284 Chinese.

5

Potent antitumor efficacy of an E1B 55kDa-deficient adenovirus carrying murine endostatin in hepatocellular carcinoma.

Li G, Sham J, Yang J, Su C, Xue H, Chua D, Sun L, Zhang Q, Cui Z, Wu M, Qian Q. Li G, et al. Among authors: su c. Int J Cancer. 2005 Feb 10;113(4):640-8. doi: 10.1002/ijc.20581. Int J Cancer. 2005. PMID: 15389517

6

[CNHK200-hA-a gene-viral therapeutic system and its antitumor effect on lung cancer].

Wang WG, Xue HB, Su CQ, Cui ZF, Nie MM, Sham J, Wu MC, Qian QJ. Wang WG, et al. Zhonghua Zhong Liu Za Zhi. 2005 Feb;27(2):69-72. Zhonghua Zhong Liu Za Zhi. 2005. PMID: 15946541 Chinese.

7

Immune gene-viral therapy with triplex efficacy mediated by oncolytic adenovirus carrying an interferon-gamma gene yields efficient antitumor activity in immunodeficient and immunocompetent mice.

Su C, Peng L, Sham J, Wang X, Zhang Q, Chua D, Liu C, Cui Z, Xue H, Wu H, Yang Q, Zhang B, Liu X, Wu M, Qian Q. Su C, et al. Mol Ther. 2006 May;13(5):918-27. doi: 10.1016/j.ymthe.2005.12.011. Epub 2006 Feb 23. Mol Ther. 2006. PMID: 16497559 Free article.

8

Increased safety with preserved antitumoral efficacy on hepatocellular carcinoma with dual-regulated oncolytic adenovirus.

Zhang Q, Chen G, Peng L, Wang X, Yang Y, Liu C, Shi W, Su C, Wu H, Liu X, Wu M, Qian Q. Zhang Q, et al. Among authors: su c. Clin Cancer Res. 2006 Nov 1;12(21):6523-31. doi: 10.1158/1078-0432.CCR-06-1491. Clin Cancer Res. 2006. PMID: 17085667

9

Antitumor activity of an hTERT promoter-regulated tumor-selective oncolytic adenovirus in human hepatocellular carcinoma.

Su CQ, Wang XH, Chen J, Liu YJ, Wang WG, Li LF, Wu MC, Qian QJ. Su CQ, et al. World J Gastroenterol. 2006 Dec 21;12(47):7613-20. doi: 10.3748/wjg.v12.i47.7613. World J Gastroenterol. 2006. PMID: 17171789 Free PMC article.

10

Gene-viral cancer therapy using dual-regulated oncolytic adenovirus with antiangiogenesis gene for increased efficacy.

Su C, Na M, Chen J, Wang X, Liu Y, Wang W, Zhang Q, Li L, Long J, Liu X, Wu M, Fan X, Qian Q. Su C, et al. Mol Cancer Res. 2008 Apr;6(4):568-75. doi: 10.1158/1541-7786.MCR-07-0073. Epub 2008 Mar 14. Mol Cancer Res. 2008. PMID: 18344493

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,700 results

Search Page

Filters